Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 15, 2014		Jun. 16, 2013
Cash flows from operating activities:
Net income	$ 78,936		$ 67,690
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	13,077		11,407
Gains on sale/disposal of assets	(1,687)		(285)
Amortization of deferred financing costs	2,771		2,853
Provision (benefit) for deferred income taxes	(2,187)		2,557
Non-cash compensation expense	8,080		10,240
Tax impact from equity-based compensation	(8,319)		(6,043)
Other	(623)		(1,090)
Changes in operating assets and liabilities	(29,258)		(20,489)
Net cash provided by operating activities	60,790		66,840
Cash flows from investing activities:
Capital expenditures	(18,948)		(11,587)
Proceeds from sale of assets	4,967		2,077
Changes in restricted cash	50,743		303
Other	(1,049)		1,266
Net cash provided by (used in) investing activities	35,713		(7,941)
Cash flows from financing activities:
Repayments of long-term debt and capital lease obligations	(12,022)		(12,219)
Proceeds from exercise of stock options	2,648		3,738
Tax impact from equity-based compensation	8,319		6,043
Purchases of common stock	(65,006)		(56,057)
Tax payments for restricted stock upon vesting	(4,363)		(2,845)
Payments of common stock dividends and equivalents	(25,130)		(11,454)
Net cash used in financing activities	(95,554)		(72,794)
Effect of exchange rate changes on cash and cash equivalents	(28)		(80)
Change in cash and cash equivalents	921		(13,975)
Cash and cash equivalents, at beginning of period	14,383	[1]	54,813
Cash and cash equivalents, at end of period	$ 15,304		$ 40,838

[1] The balance sheet at December 29, 2013 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.